Jane G. Farrar
Gründer bei Spark Therapeutics Ireland Ltd.
Aktive Positionen von Jane G. Farrar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2004 | - |
Gründer | - | - | |
Trinity College Dublin | Corporate Officer/Principal | - | - |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Corporate Officer/Principal | - | - |
Karriereverlauf von Jane G. Farrar
Ehemalige bekannte Positionen von Jane G. Farrar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Royal Irish Academy | Corporate Officer/Principal | 01.01.2009 | 01.01.2009 |
Ausbildung von Jane G. Farrar
Trinity College Dublin | Undergraduate Degree |
Statistik
International
Irland | 4 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
- Börse
- Insiders
- Jane G. Farrar
- Erfahrung